1. Friedel E, Freundlich M. European Community harmonization of the licencing and manufacturing of medicinal products. Food Drug Law J. 1994;49(1):141–170.
2. European Agency for the Evaluation of Medicinal Products. Work programme 1997–98—EMEA. Luxembourg: Office for Official Publications of the European Community; 1997.
3. Currie WJC, Löfgren M. A Practical Guide to the EMEA. Waltham MA: Parexel; 1996.
4. Bass R. Why have targets for the review process? The view of the EMEA. Improving the Regulatory Review Process: Assessing Performance and Setting Targets. Proceedings of a CMR International Workshop held at Nuffield Priory, Nuffield, UK, January 1997. McAuslane N, Walker S, editors. Dordrecht: Boston, Kluwer; 1997.
5. Shulman SR, Brown JS. The Food and Drug Administration’s early access and fast-track approval initiatives: how have they worked? Food Drug Law J. 1995;50(4):503–531.